Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
The Motley Fool reports that 58% of individual investors plan to buy more stocks in 2026, driven by AI optimism, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results